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ABSTRACT
Aims; To screen and detect individuals at ultra high risk (UHR) for psychosis and evaluate the efficacy of
a screening program
Methods: This is a two-stage study involving relatives of patients with schizophrenia. The first degree rela-
tives were screened with the GHQ-12 and non-first degree relatives were additionally screened with the self-
constructed screening questionnaires (SQ). All the positive suhjects from the initial screening will he proceed-
ed to the second stage screening.
Results: Fifteen (13.5%) of 111 subjects were positive in the first stage. After the second stage screening,
only 3 (2.7%) were positive (UHR suhject). Two (2.6%) cases were first degree relatives and the other one
(3%) was non-first degree relatives. Although the majority of the positive suhjects in the initial screening
were detected through the GHQ-12, only one of them was positive in the second stage.
Conclusion: Screening of genetic risk relatives of schizophrenia is feasible. The detection rate of subject at
UHR was much lower than expected, especially among first degree relatives. The higher detection rate among
non-first degree relatives is contrihuted by the addition of the SQ. The GHQ-12 is not suitable for screening
in early psychosis; it should he comhined with other screening instruments.
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INTRODUCTION
Some patients with schizophrenia begin with a prodro-
mal or pre-psychotic state of altered functioning or sympto-
matology before the onset of frank psychosis'^'. The
researchers viewed the prodromal period as potentially
important from a preventive aspect. Recent studies^"'
showed that the first episode of schizophrenia is a critical
therapeutic opportunity. If patients are treated promptly and
effectively, good outcome can be achieved. Longer delays
in treatment have been hypothesized to have neurotoxic
effects resulting in greater and irreversible deterioration in
brain function which is manifested clinically as greater
treatment resistance and loss of function". Thus, shortening
of duration of untreated psychosis (DUP) is critical in
determining good prognosis
An Australian group from the Personal Assessment and
Crisis Evaluation (PACE) clinic in Melbourne introduced
the 'At-Risk Mental State (ARMS)', implying that certain
sub-threshold syndrome can be regarded as a high risk fac-
tor for the development of psychosis, but that the onset of
psychosis is not inevitable*". They then developed the
Comprehensive Assessment of At-Risk Mental State
(CAARMS), a semi-structured interview designed to mea-
sure a wide variety of prodromal symptoms*'. By combined
various risk and vulnerable factors with ARMS, they are
able to identify subjects at ultra high risk (UHR). The UHR
individuals are at high risk for psychosis within a brief time
period (12 months), in contrast to the traditional approach
that employs a much longer follow-up period. Several stud-
ies'"" conducted in recent years revealed that these UHR
subjects yielded a conversion rate of 30-50%.
A local study"' found that the DUP among patients with
first episode psychosis was 159 weeks (nearly 3 years), as
compared with first episode psychoses worldwide which
was 1 to 2 years'^'". Among the solutions to the prolonged
DUB is detection the subjects at UHR and giving them
early treatment. The objectives of this study were to screen
the relatives of patients with schizophrenia and assess the
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Figure lb. Flow chart of the screening of non-first-
degree relatives
* The CAARMS scoring exceeds psychotic threshold
efficacy of the screening procedure. Schizophrenia is a
highly familial disorder that is strongly affected by genetic
influences. The first degree relatives of individuals with
schizophrenia are nearly 10 times more likely to be affected
with schizophrenia than are comparison subjects''".
METHODOLOGY
Selection of the sample
This is part of a larger study on the screening of genetic
risk relatives of schizophrenia. This region is less developed
as compared with other part of the country. More than 90%
of the populations live in rural areas. The study was
approved by the Research and Ethical Committee (Human)
of USM. This is a convenience sampling of generic risk indi-
viduals involving relatives of patients with a known (con-
firmed) case of schizophrenia (DSM-IV-TR)"' between 13 to
30 years old. The relatives were detected and interviewed by
a research assistant (RA) when they accompanying the
patients to the psychiatric clinic or visited them in the ward.
Others family members was then contacted and arranged for
the interview at home with the assistance of community
Mental Health Team (CMHT). The study subjects were
divided to two groups; the first degree and non-first degree
relatives (second degree and first cousin). First and non-first
degree relatives were assessed differently (Figure la and lb).
Assessment
Preliminary Screening
The subjects were excluded if they
a) declined to sign informed consent form
b) had been treated for psychotic illness or were being
treated with antipsychotics
c) had co-morbid substance abuse, mental retardation or
organic conditions
The preliminary (first stage) screening was conducted by
the RA. All the selected subjects (first and non-first degree
relatives) were screened with the General Health
Questionnaire (GHQ-12)"''. The questionnaire was translated
to Malay {Bahasa Malaysia) and validated prior to the study.
The cut-off point was 3. At the cut-off point the sensitivity
and specificity was 64.5% and 90.3% respectively. The non-
first degree relatives were additionally screened with the
Self-Constructed Screening Questionnaire (SQ) (available on
request)). This consisted of 10 validated questions in Malay
to detect psychotic symptoms. The questions were modified
from criteria A for schizophrenia (DSM-IV-TR)'" and
Schneider's First Rank Symptoms. The cut-off point was 2
with a maximum score of 10. The validation study conducted
before that found the sensitivity and specificity at the cut-off
point was 77.5% and 93.5% respectively.
Second Stage Assessment
All subjects who scored at or above the cut-off point pro-
ceed to the second stage. The second stage screening was
conducted by the research psychiatrists using the
CAARMS*'. If positive symptoms were detected (disorders
of thought content, perceptual abnormalities and disorga-
nized speech), further exploration was required to assess the
severity, frequency and duration of the symptoms. The sub-
jects were dropped from the study if they reached psychotic
threshold as defined in the CAARMS«' (Figure la and lb).
The positive subjects were classified into one of three
operationally define UHR sub-group«':
a)Brief limited intermittent psychotic symptoms
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Table
Table 1
Score
0
1
2
3
4
5
6
7
12
. The GHQ score of first and non-first degree relatives;
and the SQ score of non-first degree relatives
GHQ (n = 78)
47
14
9
2
1
2
0
2
1
2. No of positive cases after first and
Screening instruments
(BLIPS)
b) Attenuated
GHQ
SQ
GHQ -H SQ
psychotic
GHQ (n = 33)
19
4
6
2
1
0
0
1
0
second stage screening
Preliminary screening Second stage screening
11
3
1
symptoms (APS)
1
1
1
SQ (n = 33)
17
12
2
0
1
0
1
0
-
(UHR)
Second Stage Assessment
Detection rate (%)
9.1
33.3
100
Further assessment with GAF for both groups of rela-
tives and the schizotypal personality disorder (PD) check
list'" for non-first degree relatives were conducted to deter-
mine the third sub-group of UHR:
c) Vulnerable group (VG)
All the pos i t ive subjects were fol lowed up by the
Community Mental Health Team.
RESULTS
Preliminary Screening
A total of 111 subjects formed the final sample; 78
(70.3%) were first degree relatives, while 33 (29.7%) were
non-first degree relatives. All the subjects were ethnic
Malays. The majority were between 18-25 years old.
Among the first degree relatives, 90% were siblings to the
patients; the others were daughters or sons. None of the
parents were included due to age limit. Among non-first
degree relatives, a large proportion was niece/nephew to
the patients, followed by first cousin.
Distribution of GHQ and SQ score
There were 12 (10.8%) subjects who scored 3 and above
on the GHQ; of these 8 were first-degree relatives and the
others were non-first degree relatives. Regarding the SQ,
only 4 (12.1%) had a positive score. Out of these, 1 subject
had both positive GHQ and SQ. The detail of the scores
was shown in Table 1.
A total of 15 (13.5%) subjects entered the second stage
screening through the combination of various criteria
(Table 2). The majority had positive GHQ. Out of 15 posi-
tive subjects, 9 (60%) were first degree relatives and the
other 6 were non-first degree relatives. There was no sig-
nificant difference between the number of first and non-
first degree relatives who proceeded to the second stage
screening (-¡(^ = 0.553, df = 1, p < 0.10). After final assess-
ment, only 3 of them were positive and considered as UHR
individuals. Analysis case by case of the 3 UHR individu-
als revealed that 2 (2.6%) subjects were first-degree rela-
tives (sibling and son) and another one (3%) was non-first
degrees relative (nephew). Two cases could be classified as
APS, while the other case was a sub-group of BLIPS. One
of the subjects with APS also met the criteria of VG.
DISCUSSION
Schizophrenia is found in all societies and geographical
area, the incidence and prevalence rates are roughly equal
worldwide. About 8% of sibling and 5% of parents of a
schizophrenic individual will have schizophrenia cotnpared
to approximately 1% in the general population. Children of
schizophrenic individuals have about 12% chance of devel-
oping schizophrenia. The prevalence of the illness in sec-
ond degree relatives ranges between 2-4%, while among
the first cousin (third degree relatives), it is approximately
2%, slightly higher than general populations'"'". Thus, we
expect to detect a higher percentage of first degree than
non-first degree relatives; however, the opposite was found
in this study. The lower rate of detection among first
degree (2.6%) relatives as compared with non-first degree
relatives (3%) needs further exploration.
The GHQ-12 was not effective as the SQ in detecting
subjects at UHR. We postulated that a better detection rate
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among non-first degree relatives was related to the combi-
nation of the GHQ-12 with SQ, wbich will improve the
detection rate. Nearly the same conclusion was reached by
Donath'*', that in Australia the GHQ-12 appears to be a
less-useful instrument for detecting mental illness. We
would like to recommend that the GHQ should be com-
bined with other research/screening instruments in detect-
ing subjects with early psychosis. The combination will
improve detection rate. Tbe results showed that the detec-
tion rate was higher if the subjects were positive in more
than one screening instrument in the first stage; even
reached 100% when they were positive in both the GHQ
and SQ (Table 2). Retrospectively, we could have com-
bined the GHQ-12 with the SQ for both first and non-first
degree relatives in this study.
In Asian countries like Malaysia, stigma towards mental
illness is still strong. The majority of patients with severe
mental illness (SMI) attribute their illnesses to supernatural
agents; witchcraft or possession by evil spirits'". People
with SMI carry social stigma and the publics looks down
on them and their families^"-^". Those affected will have
emotional distress and tend to withdraw from the public. In
tbis situation the family may hide UHR individuals or pre-
vent them from meeting the researchers, wbich contribute
to the low detection rate of the potential cases. Otber
approaches such as consulting the community leader or
head of the village prior to the visit may be effective to
overcome tbis problem.
The major limitation of this study was the small sample
size and less comprehensive assessment in the initial
screening. With a bigger sample size we hope to detect
greater numbers of subjects at UHR, analyze their charac-
teristic features and assess the rate of progression to psy-
chosis within a brief period of time. In Malaysia and other
developing countries in Asia and Africa where the barrier
to psychiatric treatment is high""', it is essential to detect
and bring psychiatric patients for earlier treatment. This is
contrasted with patients in tbe developed countries where
they are actively seeking for help or help seekers"^"'.
Althougb the detection rate of subjects at UHR was lower
than expected, we feel that witb the improvement in screen-
ing procedure, the screening program would be cost-effec-
tive in view of the expensive treatment for schizophrenia,
even in a developing country such as India"'. Since the
screening procedure is simple; preliminary screening of
genetic risk relatives, especially the first degree relatives
could be conducted routinely by paramedical personnel in
primary health care centre.
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